10/28/2026
Pharma giants invest billions in psychedelics despite hurdles
Psychedelics like MDMA and psilocybin gain traction amid regulatory challenges.
Topic archive
rockville
2 stories
10/5/2026
FDA seeks public input on ibogaine research
Agency requests feedback on clinical trial design for ibogaine drug products.